Voloridge Investment Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.3M Buy
746,935
+20,969
+3% +$373K 0.05% 455
2025
Q1
$12.9M Sell
725,966
-144,189
-17% -$2.57M 0.05% 483
2024
Q4
$25.9M Sell
870,155
-158,270
-15% -$4.72M 0.09% 281
2024
Q3
$16.1M Sell
1,028,425
-76,235
-7% -$1.19M 0.06% 438
2024
Q2
$18.9M Buy
1,104,660
+46,437
+4% +$795K 0.07% 385
2024
Q1
$16.5M Sell
1,058,223
-368,501
-26% -$5.76M 0.06% 380
2023
Q4
$21.3M Sell
1,426,724
-279,864
-16% -$4.18M 0.08% 303
2023
Q3
$27.6M Buy
1,706,588
+1,484,381
+668% +$24M 0.14% 210
2023
Q2
$9.22M Buy
222,207
+211,389
+1,954% +$8.77M 0.04% 477
2023
Q1
$651K Buy
+10,818
New +$651K ﹤0.01% 1188
2022
Q3
Sell
-62,818
Closed -$4.37M 1560
2022
Q2
$4.37M Buy
62,818
+21,780
+53% +$1.51M 0.02% 724
2022
Q1
$3.4M Sell
41,038
-5,480
-12% -$454K 0.02% 780
2021
Q4
$3.49M Buy
+46,518
New +$3.49M 0.02% 851
2021
Q3
Sell
-24,599
Closed -$5.46M 1796
2021
Q2
$5.46M Sell
24,599
-209,135
-89% -$46.4M 0.04% 610
2021
Q1
$30.9M Buy
233,734
+56,851
+32% +$7.51M 0.23% 114
2020
Q4
$30.6M Buy
176,883
+95,606
+118% +$16.5M 0.26% 83
2020
Q3
$9.05M Buy
81,277
+37,727
+87% +$4.2M 0.08% 282
2020
Q2
$2.58M Buy
+43,550
New +$2.58M 0.03% 532
2019
Q4
Sell
-40,173
Closed -$3M 1276
2019
Q3
$3M Buy
40,173
+10,974
+38% +$821K 0.05% 352
2019
Q2
$1.85M Sell
29,199
-29,187
-50% -$1.85M 0.05% 337
2019
Q1
$2.81M Buy
+58,386
New +$2.81M 0.08% 228
2018
Q3
Sell
-98,290
Closed -$3.08M 419
2018
Q2
$3.08M Buy
+98,290
New +$3.08M 0.08% 228